Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1652935 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.08Day +1.89%Mkt cap $26M1Y −84.0%Off 52W high −88.3%Vol (1Y) 95.2%
Daily closing price, split-adjusted to the current basis; 1.9y shown of 488 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.2% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+2.17% |
| Top-10 13F concentration96.0% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$21.5M |
| ROE−553.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−82.4% |
| 1Y−84.0% |
| Since incept. (ann.)−65.4% |
Total return through 2026-07-29 · series begins 2024-08-13. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)95.2% |
| Ann. volatility (3Y)88.5% |
| Sharpe (1Y)−1.49 |
| Sharpe (3Y)−0.77 |
| Max drawdown (1Y)−87.8% |
| Max drawdown (3Y)−91.1% |
| Beta (3Y vs SPY)0.90 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BIOS Capital Management, LP | 10.0M | $28M | 42.00% | +0.0% |
| Voss Capital, LP | 1.7M | $5M | 7.21% | +32.7% |
| BlackRock, Inc. | 427,153 | $1M | 1.79% | −1.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 400,529 | $1M | 1.67% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 228,331 | $625,626 | 0.95% | +9.9% |
| Connective Capital Management, LLC | 113,266 | $310,349 | 0.47% | new |
| Palogic Value Management, L.P. | 100,000 | $274,000 | 0.42% | new |
| NORTHERN TRUST CORP | 97,851 | $268,112 | 0.41% | −3.5% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.24 | — | — | — |
| 2025-09-30 | 2025-11-13 | −$0.25 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$0.30 | — | — | — |
| 2025-03-31 | 2025-05-15 | −$0.32 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
